These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 22659331)

  • 1. Recent advances in nanocarrier-based mucosal delivery of biomolecules.
    Kammona O; Kiparissides C
    J Control Release; 2012 Aug; 161(3):781-94. PubMed ID: 22659331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers.
    Mishra N; Goyal AK; Tiwari S; Paliwal R; Paliwal SR; Vaidya B; Mangal S; Gupta M; Dube D; Mehta A; Vyas SP
    Expert Opin Ther Pat; 2010 May; 20(5):661-79. PubMed ID: 20345332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanocarrier possibilities for functional targeting of bioactive peptides and proteins: state-of-the-art.
    Moutinho CG; Matos CM; Teixeira JA; Balcão VM
    J Drug Target; 2012 Feb; 20(2):114-41. PubMed ID: 22023555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid lipid nanoparticles as a drug delivery system for peptides and proteins.
    Almeida AJ; Souto E
    Adv Drug Deliv Rev; 2007 Jul; 59(6):478-90. PubMed ID: 17543416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticles as protein and gene carriers to mucosal surfaces.
    de la Fuente M; Csaba N; Garcia-Fuentes M; Alonso MJ
    Nanomedicine (Lond); 2008 Dec; 3(6):845-57. PubMed ID: 19025458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some approaches to improve bioavailability of peptides and proteins through oral and other mucosal routes.
    Vyas SP; Venugopalan P; Sood A; Mysore N
    Pharmazie; 1997 May; 52(5):339-45. PubMed ID: 9183784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticles for nasal vaccination.
    Csaba N; Garcia-Fuentes M; Alonso MJ
    Adv Drug Deliv Rev; 2009 Feb; 61(2):140-57. PubMed ID: 19121350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticles as carriers for nasal vaccine delivery.
    Köping-Höggård M; Sánchez A; Alonso MJ
    Expert Rev Vaccines; 2005 Apr; 4(2):185-96. PubMed ID: 15889992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of drug safety by the use of lipid-based nanocarriers.
    Lim SB; Banerjee A; Önyüksel H
    J Control Release; 2012 Oct; 163(1):34-45. PubMed ID: 22698939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The performance of nanocarriers for transmucosal drug delivery.
    Csaba N; Garcia-Fuentes M; Alonso MJ
    Expert Opin Drug Deliv; 2006 Jul; 3(4):463-78. PubMed ID: 16822222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced mucosal vaccination by biodegradable nanoparticles.
    Park K
    J Control Release; 2009 Sep; 138(2):89. PubMed ID: 19596033
    [No Abstract]   [Full Text] [Related]  

  • 12. Bioadhesive delivery systems for mucosal vaccine delivery.
    Baudner BC; O'Hagan DT
    J Drug Target; 2010 Dec; 18(10):752-70. PubMed ID: 21039314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans.
    Mestecky J; Michalek SM; Moldoveanu Z; Russell MW
    Behring Inst Mitt; 1997 Feb; (98):33-43. PubMed ID: 9382757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanocarriers: a versatile approach for mucosal vaccine delivery.
    Mody N; Sharma R; Agrawal U; Vyas SP
    Ther Deliv; 2015 Feb; 6(2):231-45. PubMed ID: 25690089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering strategies to enhance nanoparticle-mediated oral delivery.
    Yamanaka YJ; Leong KW
    J Biomater Sci Polym Ed; 2008; 19(12):1549-70. PubMed ID: 19017470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanocarrier systems for oral drug delivery: do we really need them?
    Bernkop-Schnürch A
    Eur J Pharm Sci; 2013 May; 49(2):272-7. PubMed ID: 23537503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in topical delivery of proteins and peptides mediated by soft matter nanocarriers.
    Witting M; Obst K; Friess W; Hedtrich S
    Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1355-69. PubMed ID: 25687276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons from nature: "Pathogen-Mimetic" systems for mucosal nano-medicines.
    Mrsny RJ
    Adv Drug Deliv Rev; 2009 Feb; 61(2):172-92. PubMed ID: 19146895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges and advances in nanoparticle-based oral insulin delivery.
    Ramesan RM; Sharma CP
    Expert Rev Med Devices; 2009 Nov; 6(6):665-76. PubMed ID: 19911877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan-based delivery systems for protein therapeutics and antigens.
    Amidi M; Mastrobattista E; Jiskoot W; Hennink WE
    Adv Drug Deliv Rev; 2010 Jan; 62(1):59-82. PubMed ID: 19925837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.